NO975660D0 - Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi - Google Patents
Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemiInfo
- Publication number
- NO975660D0 NO975660D0 NO975660A NO975660A NO975660D0 NO 975660 D0 NO975660 D0 NO 975660D0 NO 975660 A NO975660 A NO 975660A NO 975660 A NO975660 A NO 975660A NO 975660 D0 NO975660 D0 NO 975660D0
- Authority
- NO
- Norway
- Prior art keywords
- benzimidazoles
- drug
- manufacture
- treatment
- liver chemistry
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47381795A | 1995-06-07 | 1995-06-07 | |
| PCT/US1996/007445 WO1996040122A1 (en) | 1995-06-07 | 1996-05-22 | Use of benzimidazoles for the manufacture of a medicament for the treatment of leukemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO975660D0 true NO975660D0 (no) | 1997-12-05 |
| NO975660L NO975660L (no) | 1998-02-09 |
Family
ID=23881113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO975660A NO975660L (no) | 1995-06-07 | 1997-12-05 | Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av leukemi |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0831816A1 (no) |
| JP (1) | JPH11506732A (no) |
| KR (1) | KR19990022617A (no) |
| CN (1) | CN1186433A (no) |
| AR (1) | AR003137A1 (no) |
| AU (1) | AU717382B2 (no) |
| BR (1) | BR9608730A (no) |
| CA (1) | CA2223435A1 (no) |
| CZ (1) | CZ391197A3 (no) |
| HU (1) | HUP9802634A3 (no) |
| IL (1) | IL118424A0 (no) |
| NO (1) | NO975660L (no) |
| PL (1) | PL324026A1 (no) |
| SK (1) | SK168697A3 (no) |
| TR (1) | TR199701536T1 (no) |
| WO (1) | WO1996040122A1 (no) |
| ZA (1) | ZA964373B (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6479526B1 (en) | 1995-04-12 | 2002-11-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| US6177460B1 (en) | 1995-04-12 | 2001-01-23 | The Procter & Gamble Company | Method of treatment for cancer or viral infections |
| US6262093B1 (en) | 1995-04-12 | 2001-07-17 | The Proctor & Gamble Company | Methods of treating cancer with benzimidazoles |
| US5770616A (en) | 1995-06-07 | 1998-06-23 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
| US6265427B1 (en) | 1995-06-07 | 2001-07-24 | The Proctor & Gamble Company | Pharmaceutical composition for the method of treating leukemia |
| US6686391B2 (en) | 1995-08-04 | 2004-02-03 | University Of Arizona Foundation | N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions |
| US5900429A (en) | 1997-01-28 | 1999-05-04 | The Procter & Gamble Company | Method for inhibiting the growth of cancers |
| US6506783B1 (en) | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
| US6245789B1 (en) * | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
| US6423734B1 (en) | 1999-08-13 | 2002-07-23 | The Procter & Gamble Company | Method of preventing cancer |
| US6462062B1 (en) | 2000-09-26 | 2002-10-08 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6407105B1 (en) | 2000-09-26 | 2002-06-18 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6380232B1 (en) | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
| US6608096B1 (en) | 2000-09-26 | 2003-08-19 | University Of Arizona Foundation | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| EP2251010A1 (en) | 2009-05-08 | 2010-11-17 | Sygnis Bioscience GmbH & Co. KG | Use of thiabendazole and derivatives thereof for the therapy of neurological conditions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL134354C (no) * | 1963-05-23 | |||
| FR2155888A1 (en) * | 1971-10-13 | 1973-05-25 | Agot Aime | Solid anthelmintic composn - for more economical treatment of ruminants |
-
1996
- 1996-05-22 PL PL96324026A patent/PL324026A1/xx unknown
- 1996-05-22 AU AU58020/96A patent/AU717382B2/en not_active Ceased
- 1996-05-22 EP EP96914749A patent/EP0831816A1/en not_active Withdrawn
- 1996-05-22 KR KR1019970709098A patent/KR19990022617A/ko not_active Application Discontinuation
- 1996-05-22 CN CN96194465A patent/CN1186433A/zh active Pending
- 1996-05-22 BR BR9608730A patent/BR9608730A/pt not_active Application Discontinuation
- 1996-05-22 CA CA002223435A patent/CA2223435A1/en not_active Abandoned
- 1996-05-22 WO PCT/US1996/007445 patent/WO1996040122A1/en not_active Application Discontinuation
- 1996-05-22 TR TR97/01536T patent/TR199701536T1/xx unknown
- 1996-05-22 SK SK1686-97A patent/SK168697A3/sk unknown
- 1996-05-22 CZ CZ973911A patent/CZ391197A3/cs unknown
- 1996-05-22 JP JP9500667A patent/JPH11506732A/ja active Pending
- 1996-05-22 HU HU9802634A patent/HUP9802634A3/hu unknown
- 1996-05-27 IL IL11842496A patent/IL118424A0/xx unknown
- 1996-05-29 ZA ZA964373A patent/ZA964373B/xx unknown
- 1996-06-07 AR ARP960103043A patent/AR003137A1/es not_active Application Discontinuation
-
1997
- 1997-12-05 NO NO975660A patent/NO975660L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9802634A3 (en) | 1999-05-28 |
| WO1996040122A1 (en) | 1996-12-19 |
| TR199701536T1 (xx) | 1998-02-21 |
| AR003137A1 (es) | 1998-07-08 |
| CN1186433A (zh) | 1998-07-01 |
| BR9608730A (pt) | 1999-06-29 |
| ZA964373B (en) | 1996-09-02 |
| EP0831816A1 (en) | 1998-04-01 |
| SK168697A3 (en) | 1998-12-02 |
| AU717382B2 (en) | 2000-03-23 |
| KR19990022617A (ko) | 1999-03-25 |
| JPH11506732A (ja) | 1999-06-15 |
| IL118424A0 (en) | 1996-09-12 |
| HUP9802634A2 (hu) | 1999-03-29 |
| CZ391197A3 (cs) | 1998-05-13 |
| PL324026A1 (en) | 1998-05-11 |
| AU5802096A (en) | 1996-12-30 |
| CA2223435A1 (en) | 1996-12-19 |
| NO975660L (no) | 1998-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2013020I2 (el) | Η χρηση μιας ενωσης ινγκενανης για την κατασκευη ενος φαρμακου για την θεραπεια του καρκινου | |
| NO965377L (no) | Indolinonforbindelser for behandling av sykdommer | |
| DK0730864T3 (da) | Lægemiddel til behandling af inflammatoriske hjertesygdomme | |
| ATE192157T1 (de) | Therapeutisch verwendbare spiro-azabicyclische verbindungen | |
| ATE193298T1 (de) | Therapeutische verbindungen | |
| NO20040145L (no) | Anvendelse av benzensulfonamidderivater for fremstilling av et medikament | |
| NO990225D0 (no) | Medikamenter for behandling av hyperfosfatemi | |
| NO975661D0 (no) | Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer | |
| NO975660D0 (no) | Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi | |
| FI962370A0 (fi) | Laite tissuen valmistamiseksi | |
| NO995251D0 (no) | FremgangsmÕte for administrering av haloterapi | |
| NO953254D0 (no) | Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter | |
| BR9610214A (pt) | Compostos farmacéuticos | |
| EE03384B1 (et) | Melatoniini kasutamine ravimi tootmiseks | |
| NO993627D0 (no) | Anvendelse av en forbindelse for fremstilling av et legemiddel | |
| EE03437B1 (et) | Benseenamiidid neurodegeneratiivsete haiguste ravimiseks | |
| NO973366D0 (no) | Fremgangsmåte for behandling av multippel sklerose | |
| NO982562D0 (no) | Sammensetning for behandling av smerte | |
| NO20000811D0 (no) | Fremgangsmåte for valg av medicament | |
| DK0866699T3 (da) | Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi | |
| NO20003393D0 (no) | FremgangsmÕte for fremstilling av en farmasøytisk formulering | |
| NO993549D0 (no) | Imino-aza-antracyklinonderivater til behandling av amyloidosis | |
| NO20002481D0 (no) | Kombinasjonsterapi for behandling av AIDS | |
| NO965448L (no) | Farmasöytiske forbindelser | |
| LV11966A (lv) | Pretiekaisumu lidzeklis arigai lietosanai |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |